Press
Release:
July
16, 2003
Contact
Information
Patricia
Weathers 845-677-8115
President
Sheila
Matthews
203-966-8419
National
Vice President
Ablechild
is thrilled to learn that Senator John Ensign of Nevada has sponsored “The
Child Medication Safety Act” in the Senate.
With parents speaking out from every State in the Union, this federal
action taken will ensure that those calls are heard.
The dramatic rise of the diagnosing of subjective mental illnesses and
the forced drug “treatment” on children in the public education system has
reached the Senate. On our website
alone, www.ablechild.org we have over
300 signatures of parents nationwide that have experienced this coercion to drug
their children by schools.
America
is clearly facing a crisis regarding the lack of informed consent and the right
to refuse psychological services and drug treatments promoted by the mental
health industry within the school system.
Mr.
Lawrence Smith, whose son died from heart failure caused by a prescribed
stimulant recommended by the school, couldn’t have put it more clearly to the
point when he stated that, “I cannot go back and change things for us at this
point; however, I hope to God my story and information will reach the hearts and
minds of many families, so they can make an educated decision.”
The Child Medication Safety Act would prevent families like the Smith’s
from losing their children needlessly by undue pressure to use behavioral drugs
via the education system.
We encourage the media to educate parents of the dangers associated with the labeling and drugging of our children currently being promoted and pushed with selective research within the public education system. We commend Senator Ensign for his courage to sponsor such an important basic parental rights bill. We continue to encourage all parents to reach out to their federal senators and request that they sign onto this important bill as well. Only by doing this, will parents protect their right to choose and ensure their children’s health, safety, and well-being.